CD4+ T cells are a major focus of TB vaccine development due to their central and multifaceted role in the immune response to Mtb infection (Bell and Noursadeghi, 2018; Mogues et al., 2001; Bromley et al., 2024). This evidence concerns the gene CD4 and tuberculosis.